Chemical formula: C₂₃H₃₁NO₇ Molecular mass: 433.495 g/mol PubChem compound: 5281078
Mycophenolate mofetil is the 2-morpholinoethyl ester of mycophenolic acid (MPA). MPA is a potent, selective, uncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase, and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L04AA06 | Mycophenolic acid | L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AA Selective immunosuppressants |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| CELLCEPT Powder for concentrate for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC | |
| CELLCEPT Capsules, hard | European Medicines Agency (EU) | MPI, EU: SmPC |
Mycophenolate mofetil is an active ingredient of these brands:
Canada (CA)France (FR)Israel (IL)Japan (JP)Mexico (MX)Nigeria (NG)Romania (RO)South Africa (ZA)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
